Gelonghui, April 28 | Xinbang Pharmaceutical (002390.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 1,582 billion yuan, down 1.41% year on year; net profit attributable to shareholders of listed companies was 588.24,800 yuan, up 11.11% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 5881.19 million yuan, up 14.70% year on year; basic earnings per share were 0.03 yuan.
信邦制药(002390.SZ)：一季度净利润5882.48万元 同比增长11.11%
Xinbang Pharmaceutical (002390.SZ): Net profit of 58.824,800 yuan in the first quarter increased 11.11% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.